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Psychiatric patients are particularly affected by symptoms of insomnia. Because 
insomnia is often secondary to other conditions and was once thought to be less treatable, 
this condition has received little attention in terms of treatment and research. Additionally, 
psychiatric patients have typically fewer resources to seek treatment. Generally, insomnia 
is treated with medications that may have biological side effects and offer little restorative 
sleep. Behavioral or cognitive interventions have often been overlooked. This experiment 
uses profile analysis to test the hypothesis that psychiatric outpatients randomized to a 
treatment group would  have decreased levels of sleep difficulties (measured by PSQI) 
when levels of depression (measured by PHQ-9) were  held constant compared to 
participants in a control/wait group. Also, it was hypothesized that levels of depression 
 ix 
would decrease in the treatment group when initial levels of sleep difficulties were held 
constant compared to participants in a wait group. Levels of sleep difficulty were found to 
be significantly lower in the treatment group than the wait group at post and follow up. 
Levels of depression were found to be significantly lower in the treatment group than in 
the wait group at post and follow up. The treatment group received one, 50-minute, 
individual therapy session that addressed sleep hygiene, stimulus control and sleep 
restriction activities and also received an additional telephone session two weeks later. 
These findings suggest that providing behavioral and cognitive interventions may be a 
feasible alternative to using pharmacological interventions as a first-line treatment for 
insomnia.  
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Chapter 1  
Introduction 
 
 The National Institute of Health reported in 2007 that 40 million Americans would 
suffer from a chronic sleep disorder in that year (NIH, 2007). The cost to Americans will 
be $16 billion in direct medical expenses in addition to lost productivity at work and home, 
automobile accidents caused by drowsy drivers, decreased personal wellness and fewer 
satisfying social interactions (NIH, 2007).   
 Once thought of as a dormant or passive state of being, sleep is now understood to 
be an important part of physical and mental wellbeing, maintenance and growth. This 
active state of rest and rejuvenation has many facets that, in concert, have specific and 
necessary functions. The National Institute on Neurological Disorders and Stroke reported 
that these functions of sleep are not fully understood (NIH, 2007). Better understood are 
the symptoms of not getting adequate sleep. The severity of these symptoms suggests that 
sleep is a necessary component of human survival, health and wellbeing. 
  Unfortunately, millions of people suffer from a lack of sleep each year (NIH, 
2007). Problems with sleep or insomnia can be defined in many different ways (Perlis, 
Jungquist, Smith, & Posner, 2005).  The common components of these definitions are 
threefold and require each of the following: (1) the inability to fall asleep for a period of 
time over a number  of days; (2) the opportunity to fall asleep is present (graduate school 
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may preclude insomnia when the opportunity to sleep is not present); and (3) a significant 
impairment is experienced during the day.  
 Insomnia has traditionally been treated with medication that can have adverse side 
effects and may not improve the amount of restful sleep received. Behavioral and cognitive 
therapies have been used with success. These therapies have been tested in group formats 
(Jansson & Linton, 2005), within general adult populations (Bélanger, Savard & Morin, 
2006), within child populations (Weiss, Wasdell, & Bomben, 2006) and within older 
populations (Rybarczyk, Stepanski, Fogg, Lopez, Barry, & Davis, 2005). However, the 
effects of such interventions are not fully understood, especially with populations such as 
those with co-morbid diagnoses of depression and other psychological conditions. 
 A population that is particularly affected by symptoms of insomnia are  psychiatric 
patients (Dashevsky & Kramer, 1998). Because secondary insomnia (secondary to other 
conditions) was once thought to be less treatable, this population has received little 
attention in terms of treatment and research (Perlis, et al., 2005). They are also less likely 
to have resources to find treatment for insomnia. When resources are available, psychiatric 
patients may also be less likely to take advantage of these opportunities (Dashevsky & 
Kramer, 1998). 
 This study will evaluate the implementation of a brief CBT intervention for 
insomnia among psychiatric patients with a co-morbid diagnosis of depression. An 
assessment will be made as to whether the principles of insomnia treatment, which have 
been shown to be effective among other populations, can be incorporated into brief 
interventions among psychiatric populations experiencing depression. The brief 
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interventions, if found to be effective, would be helpful to mental health professionals 
working in medical settings who have limited  time  and resources to spend with patients. 
This specifically answers the call of Danish, Forneris & Wilder-Schaaf (2007) to address 
the context in which health care is delivered. These brief interventions will make treatment 
modalities available to less advantaged populations who may not have opportunities to 
receive them elsewhere. 
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Chapter Two 
Literature Review 
 
 The following literature review will delineate the relevant issues leading up to the 
current research problem. It is important to understand the function and architecture of 
sleep in order to contextualize the problem of insomnia. Also, links between insomnia and 
depression will be presented followed by a discussion of the current understanding of the 
various medicinal and cognitive treatments of insomnia.  
Function of Sleep 
There are many hypotheses about the function of sleep. Some believe that the 
ancient behavior of sleep originally developed in animals to conserve energy or suppress 
hunger at night when obtaining food is more difficult (Berger & Phillips, 1995). Another 
possible protective function of sleep is to allow animals to lie still during their most 
vulnerable hours and hide from predators (Lima & Rattenborg, 2007). Among humans, 
more popular beliefs and assumptions of the purpose for sleep have been to consider it a 
venue for the ‘resetting of the brain’ or simply a chance to rest physically and mentally 
(Siegel, 2005).   
 Scientific inquiry has led to evidence that sleep has a more specific and necessary 
function. Studies have shown that increased REM sleep occurs after learning and that 
learning decreases after REM deprivation (Peigneux, Laureys, Delbeuck, & Maquet, 2001; 
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Stickgold, Hobson, Fosse, & Fosse, 2001), which may suggest a link between sleep and 
learning.  
 The brain is not ‘hardwired’ but pliable. Information stored in the brain is 
distributed instead of stored in one location. This redundancy creates a robustness that 
allows information to be retained if a few synapses or neurons are lost. Also, the 
information is superimposed; meaning one neuron is responsible for more than one piece 
of information (Delcomyn, 1997). Though the idea that neuroplastic changes are 
consolidated during sleep is controversial among many (Crick & Mitchison, 1983), it can 
be deduced that for the brain to store, distribute and then consolidate the amount of 
information necessary for functioning, a reprocessing and allocating time would be 
necessary. It has been postulated that REM is the reprocessing and allocating of this 
information to create an efficient mind. This idea dovetails with the experience that many 
people have as they sleep and dream of recent and past events.  
 Siegel (2001) and Vertes and Eastman (2000) argue that the decrease in learning 
that accompanies losses in sleep is actually a function of a mediating variable, stress. Other 
studies produce convergent results that begin to suggest that sleep is necessary for some of 
the neural plasticity of brain functioning (Frank, Issa, & Stryker, 2001; Hobson, 1989).  
 Hobson and Pace-Schott (2002)  have outlined this process in detail on a 
neurological level. They concluded that the brain is active during waking hours to interact 
with the world, is less active during non-REM sleep to allow information to be 
consolidated in the forebrain, and then reactivated during REM sleep to cortically integrate 
with previously stored information that was consolidated during non-REM sleep. This 
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pattern of sleep or sleep architecture is consistent with brain wave activities measured in 
humans while asleep.  
Sleep Architecture 
 Sleep may have been considered by some to be a passive state of rest (Siegel, 
2005). However, sleep is now understood to be an active state with specific frequencies of 
brainwaves that denote defined stages of sleep (Pinel, 1992). These stages, along with tools 
used for detecting these stages will be described below. 
 Three fundamental measures are used to define stages of sleep through the 
detection of brainwaves. Electroencephalogram (EEG) is used as a gross measure of 
electrical activity emitted by the brain. Electromyogram (EMG) is used to measure muscle 
tone. Electro-oculogram (EOG) is used to measure eye movement. These measures are 
collectively called polysomnography (PSG) (Dement, 1978). Advances in quantitative 
electrophysiology, the advent of functional neuroimaging and the ability to record the 
waking and sleep of subjects outside the sleep laboratory, have expanded the information 
we can gather about brain activity during sleep (Hobson & Pace-Schott, 2002).  
 Perlis (2005) has described the four fundamental types of EEG activity measured in 
sleep research. These are beta, alpha, theta and delta waves. Beta waves are associated with 
wakefulness. They range from about 15 to 35 hertz (Hz) and are the least consistent in their 
pattern because of spontaneous wakeful activities such as sensory, motor and cognitive 
tasks. Beta waves are the highest in frequency (more waves per millisecond) and lowest in 
amplitude (lower peaks and troths).   
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 Alpha waves become predominate during wakefulness that is more relaxed. These 
waves are more synchronous with decreased frequency and increased amplitude. Activities 
that promote alpha waves such as meditation and relaxation may lead to positive health 
benefits.  
 The first stage of sleep is characterized by theta waves. These waves are measured 
by EEG and are  slower in frequency and greater in amplitude than alpha waves. Deeper 
stages of sleep are characterized by delta waves. They are the slowest in frequency and 
largest in amplitude of brain waves (Perlis et al., 2005).    
 Pinel (1992) presented an overview of the states of sleep. The first four stages of 
sleep are known as non-REM sleep and correspond with the four types of brain waves 
described above. Stage 1 Sleep is the first stage of sleep and also the stage of sleep that 
occurs when one is aroused from any of the other stages. A person awakened in this stage 
of sleep may feel as if they were not yet asleep. A person in Stage 1 Sleep may have slow 
and rolling eye movements. Stage 2 Sleep is deeper than stage one and characterized by 
delta waves. One may spend up to 50% of a normal sleep period in Stage 2 Sleep. Stage 3 
and Stage 4 Sleep are made up of delta wave sleep. These stages are similar and only 
discriminated by slight variations in the amount of delta waves present.  
 REM sleep is a fifth stage of sleep that occupies between 15% and 25% of a normal 
sleep cycle. It is known as the deepest stage of sleep and is characterized by rapid eye 
movement and paralysis of voluntary muscles.  
 Stages 1 through 4 usually last 5 to 15 minutes each. These Non-REM stages 
usually progress in the order of stage 1, 2, 3, 4, 3, 2, REM. Disturbance from any of these 
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stages results in a return to Stage 1 Sleep. These various waves organized within stages 
make up a circadian rhythm. This rhythm is controlled by hormones and influenced by 
external factors such as light and temperature. This rising and falling rhythm dictates the 
optimal time for falling and staying asleep (Lack & Wright, 2007). This concert of internal 
and external factors making up a circadian rhythm has a high inertia and resists change. It 
has been shown that adjusting to as many of these dictating factors as possible can, in 
many cases, shift this circadian rhythm when needed. For example, a strong influencing 
factor to this rhythm is bright morning light. Lack, Wright and Paynter (2008) 
demonstrated that this morning light can not only reduce sleep latencies and frequency of 
nocturnal awakenings but can actually adjust the circadian rhythm measured by internal 
human melatonin release.   
 The above stages describe the shape of sleep and can be measured objectively by 
polysomnography. Subjective self-reported estimates such as sleep latency, number of 
nocturnal awakenings and sleep efficiency are also used to measure sleep and are as useful 
as more objective measures. Sleep continuity is a measure of how efficiently and 
effectively these stages are occurring. The five variables of sleep continuity are Sleep 
Latency (SL), Frequency of Nocturnal Awakenings (FNA), Wake After Sleep Onset 
(WASO) time, Total Sleep Time (TST) and Sleep Efficiency (SE%) (Perlis, et al., 2005).  
Consequences of Sleep Deprivation 
Because of gender differences, individual sleep-need variances, sleep-need 
differences among age groups and other variables, it is difficult to predict how much sleep 
any one individual needs (Perlis, et al., 2005).  In humans, too little sleep results in 
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drowsiness, reduced levels of concentration and impaired memory and physical 
functioning (Morin, 1996). More prolonged deprivations from sleep result in hallucinations 
and mood fluctuations. Rats have a normal life span of 2 to 3 years. Death occurs after 5 
weeks if deprived of REM. Total deprivation of sleep from rats results in a more speedy 
death of only 3 weeks (NIH, 2007). 
Insomnia  
 Many in the medical field such as the World Health Organization (1993) define 
insomnia in the International Classification of Disease (ICD-10) as a problem initiating 
and/or maintaining sleep for three or more nights a week (WHO, 1992). It may also be a 
complaint of non-restorative sleep for the same period of time and must be associated with 
daytime distress or impairment.  
 The American Psychiatric Association (1994) differentiates sleep problems that are 
an entity unto themselves, such as primary insomnia, and sleep problems that are a result 
of some other medical or psychiatric condition (secondary insomnia). In the DSM-IV-TR, 
insomnia is defined as an independent condition causing significant distress and daytime 
impairment. It is signified by a predominant complaint or difficulty initiating or 
maintaining sleep or a failure to achieve non-restorative sleep (APA, 1994).  
 The American Academy of Sleep Medicine has defined primary insomnia by 
focusing on the cause of the condition. The International Classification of Sleep Disorders–
Revised defines insomnia by how it is initiated and maintained (ASDA, 1997). The term 
psychophysiologic insomnia is a learned sleep-preventing association that results in 
complaints of not being able to sleep and feelings of distress during wakeful hours. This 
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somatic association is signified by increased muscle tension, rapid heart rate, sweating and 
other nervous symptoms while attempting to sleep (ASDA, 1997). This definition focuses 
on the classical conditioning that takes place between bedtime routines, environments and 
thoughts about sleep.  
 Beyond these definitions, other signifiers of specificity could be used to classify 
different types of unwanted arousal from sleep. Initial insomnia refers to problems falling 
asleep. Middle insomnia or sleep maintenance refers to prolonged periods of wakefulness 
after falling asleep but before morning. Terminal insomnia describes the condition of 
awakening too early and being unable to fall back to sleep (Perlis, et al., 2005).  
 Arbitrary distinctions in classifying the duration of insomnia separate acute and 
chronic insomnia. Acute insomnia is usually considered some sleep condition lasting less 
than six months. Acute insomnia usually has an etiologic underpinning such as stress, pain 
or substance abuse. Chronic insomnia lasts for over six months and its causes may be more 
amorphous (Rajput & Bromley, 1999). 
 Frequency and intensity of insomnia varies among sufferers of this condition 
(Rajput & Bromley, 1999). Many who suffer from insomnia do not have symptoms every 
night. When these symptoms occur, they may occur to different degrees. One may report 
that he is having daytime distress from a lack of sleep and is experiencing initial insomnia 
for up to 20 minutes, four times a week. Compared to some, these symptoms may be 
considered mild. Some have suggested that though somewhat arbitrary, cutoff rates for 
classifying primary, middle or terminal insomnia should be 30 minutes or greater 
(Lichstein et al., 2002). This distinction is based on the level of typical complaints that 
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arise in population studies. Therefore, this is a definition based on what is acceptable 
among a culture.  
 The definitions of insomnia presented in the ICD-10, DSM-IV-TR and ICDS-R are 
subjective definitions. It allows room for the patient to define her or his own complaint. 
The subjective components, daytime distress and non-restorative sleep, are helpful because 
patients can determine if this condition is distressing. Yet, the lack of objectivity can make 
research in the area less precise. Though this problem is addressed to some extent by 
distinguishing between primary and secondary insomnia, it is often the case that similar 
diagnoses are made for very different conditions (Rajput & Bromley, 1999). Restless leg 
syndrome, sleep apnea, learned sleep-preventing associations, newborn babies in the home, 
loud neighbors and nocturnal pets may all results in non-restorative sleep and daytime 
impairments.  
 The different views of the definition of insomnia have been presented above. 
Objective and technical views may be helpful in understanding the mechanisms of the 
condition. More global and patient-centered views may be sufficient in many cases for 
treating insomnia since it often is the patient’s experience of this condition that is being 
treated.  
Depression and Insomnia 
 Five of the nine criteria for major depressive episode in the DSM-IV-TR are related 
to, highly correlated with or are insomnia itself. Of these nine criteria for depression, 
insomnia is the most prevalent (Perlis, Giles & Buysse, 2007). Recent studies (National 
Institute of Health, 2005) suggest that insomnia and depression are more than correlates 
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and have more than a simple cause and effect relationship. In fact, these two conditions 
appear to have a reciprocal relationship in which one or the other may influence, 
perpetuate, exacerbate or maintain the other (Turek, 2005). A recent pilot study (Taylor, 
Lichstein & Weinstock, 2007) that treated a small number of participants with a CBT 
intervention for insomnia revealed that mild symptoms of depression decreased in all 
participants and were maintained for three months. It is interesting to note that no 
interventions for depression were administered in this study but the symptoms of 
depression responded to the CBT intervention for insomnia.  
Treatment of Insomnia with Medication 
 Medication has been a common intervention for treating insomnia (Holbrook, 
Crowther, Lotter, Cheng & King, 2000). Benzodiazepines have been prescribed often for 
reducing symptoms of insomnia because of their sedative effect. Accompanying this effect 
are hypnotic, anxiolytic, anticonvulsant, muscle relaxant and amnesic properties. This 
psychoactive drug slows the central nervous system and make sleep more likely. However, 
because this drug is habit- forming and comes with many side effects, it should not be a 
first choice for long-term treatment of insomnia (Espie, 1991). Newer drugs such as 
Ambien and Sonata are benzodiazepine receptor agonists. Some of the newer drugs are 
more specific in that they are helpful for falling asleep whereas others are helpful for 
staying asleep. However, because of side effects and often nominal increases in restorative 
sleep, they still should not be prescribed without first trying non-chemical strategies and 
considering the risks (Glass, Lanctôt, Hermann, Sproule, & Busto, 2005). The outcome of 
these medications is often a hypnotic forgetting of the stress of the restless night without 
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adding natural restorative sleep. This effect can be helpful over short time periods after 
considering the risk of side effects. Genevie`ve Belleville and Charles M. Morin (2008) 
demonstrated that chronic users of benzodiazepines that stopped using the medication for 
insomnia experienced fewer symptoms of insomnia, anxiety, distress and increased levels 
of self-esteem after controlling for readiness to change, current stage of change, levels of 
psychological distress, health and self-efficacy.  
Cognitive and Behavioral Treatment of Insomnia  
 Effective non-medicinal treatments of insomnia will be presented below. It will be 
shown that several techniques exist that are effective in reducing patients’ symptoms of 
insomnia without the risk of medicine-induced side effects.  
 Dashevsky and Kramer describe progressive muscle relaxation training, imagery 
training, biofeedback, and hypnosis as having been used as relaxation treatments for 
insomnia. Sets of structured exercises are used to teach a person to relax and reduce 
tension in order to fall asleep. Some medical conditions, medications or psychological 
conditions could render this treatment useless (1998). 
 Stimulus control is a method of overcoming cues in the bedroom that contribute to 
insomnia through classical conditioning (Bootzin, 1972). These methods of establishing 
good sleep hygiene include using the bed and bedroom only for sleep or sex. This includes 
avoiding watching television, reading or working in the bedroom. Stimulus control 
therapies work best when a regular sleep and wake schedule can be established and when 
daytime napping is avoided. The stimulus control method discourages people from lying in 
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bed beyond 20 minutes if not yet asleep to avoid establishing or strengthening a tie 
between wakefulness and the bed (Bootzin, 1972).     
 Sleep restriction is a method of reducing symptoms of insomnia by reducing the 
amount of wakeful time in bed. Some assume that more time in bed will result in more 
time asleep. However, this time may not be restful sleep or may augment symptoms of 
insomnia as described above. In Sleep Restriction, sleep logs are used to estimate the time 
in bed and the time asleep. Once a baseline is formed, a limited amount of time in bed is 
prescribed which is usually the average time logged sleeping plus 30 minutes. At first, the 
patient becomes more tired during the day. If daytime napping is avoided, nighttime sleep 
becomes more consolidated and restful. Time-in-bed prescriptions are increased by 10 or 
15 minutes while sleep is relatively good but daytime tiredness continues. Time-in-bed 
prescriptions are decreased when sleep is non-restful (Spielman, 1987). The goal is to 
increase the amount of efficient sleep in bed. Sleep pressure is maintained by restricting 
sleep until the body and mind learn to sleep efficiently.  
 Cognitive behavioral therapy (CBT) for insomnia addresses irrational beliefs about 
sleep that are counterproductive to sleep.  Examples of common and erroneous beliefs are 
that everyone should have 8 hours of sleep each night and that sleepless nights will render 
a person incapable of functioning the next day. Both of these beliefs can increase insomnia 
symptoms by increasing tension and anxiety. Neither of these beliefs is true. In addition, 
CBT is aimed at modifying maladaptive sleep habits, reducing autonomic and cognitive 
arousal and educating patients about healthier sleep hygiene practices (Morin, 1993).  
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 Evidence for the efficacy of CBT for insomnia is strong. Meta-analysis studies 
suggest that CBT interventions produce reliable and durable changes in the sleep of 
patients with chronic insomnia (Morin, Hauri, Espie, Spielman, Buysse & Bootzin, 1999). 
Reductions in symptoms of insomnia through CBT have been shown to last up to 2 years 
(Morin, Colecchi, Stone, Sood & Brink, 1999). CBT has been shown to be superior to 
pharmacological treatments in a meta-analysis study by having more sustained 
improvements in sleep patterns of participants (Smith, Perlis, Park, Smith, Pennington, 
Giles & Buysse, 2002) and has been shown to be preferred by patients (Morin, Gaulie, 
Barry, Kowatch, 1992).  
 These behavioral interventions have been effective but often not efficient. They 
take six to twelve sessions and require the expertise of a psychologist trained in CBT 
interventions for insomnia. Nurses have been given brief training for CBT interventions for 
insomnia. Subsequently, the interventions delivered by these nurses to participants in a 
randomized medical trial (Espie, Fleming & Cassidy, 2008) had similar success rates 
among some participants at reducing symptoms of insomnia as interventions delivered by 
psychologists. This suggests that efficient interventions may be effective in reducing 
symptoms of insomnia.  
 The preceding review of literature details the current understanding of the need for  
 
and the function of sleep. The shape of sleep (sleep architecture) and consequences of  
 
disruptions in this architecture were presented. Prolonged disruptions may lead to  
 
medicinal or cognitive treatments of insomnia with varying effects. Evidence for the 
 
efficacy and advantage of cognitive and behavioral treatments was presented and shown  
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to be strong. 
  
Problem 
 A population that is particularly effected by symptoms of insomnia is psychiatric 
patients. Because secondary insomnia (secondary to other conditions) was once thought to 
be less treatable, this population has received little attention in terms of treatment and 
research (Perlis, et al., 2005). This population is also less likely to have resources to find 
treatment for insomnia. When resources are available, psychiatric patients may be less 
likely to take advantage of these opportunities. 
Hypothesis 
 Psychiatric outpatients participating in a brief intervention for insomnia will have 
significantly lower PSQI scores (a global measure of sleep) at post and follow up 
compared to a control group not receiving the intervention. 
 Also, psychiatric outpatients participating in a brief intervention for insomnia will 
have significantly lower PHQ-9 scores (a measure of depression) at post and follow up 
compared to a control group not receiving the intervention. 
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Chapter Three 
Method 
 
Participants 
 Thirty-four volunteer adult outpatients of a psychiatric hospital housed inside a 
medical school were recruited as participants. This clinic serves individuals with a full 
range of socio-demographic characteristics but consumers of services tend to have lower 
incomes because of the training component present in the clinic. Participants accepted into 
this study scored 5 or greater on the PSQI and 10 or greater on the PHQ-9. This indicates 
that the population is made up of participants with significant co-morbid symptoms of 
depression and insomnia.   
 The mean age of participants was 44.9 years of age with a range of 21 to 62 years. 
Females made up 73.5% of the study group, whereas males accounted for the remaining 
26.5%. Self-reported racial make-up of the study population indicated that 55.9% of the 
population identified themselves as African-American and 44.1% identified themselves as 
Caucasians. Some 20.5% of the group reported that they did not complete high school; 
61.9% of participants did complete high school. The remaining 17.7% of responders 
completed college or a post-graduate degree. Table 1 below describes the participants 
according to their randomly assigned group. 
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Table 1 
 
Description of participants by group 
 Treatment Wait 
 
Gender 
  
 
       Female 
 
18 
 
7 
 
       Male 
 
6 
 
3 
 
Mean Age in Years 
 
43 
 
48 
 
Race 
  
 
       Caucasian 
 
16 
 
3 
 
       African-American 
 
8 
 
7 
 
Marital Status 
  
 
       Married 
 
7 
 
0 
 
       Single  
 
8 
 
6 
 
       Separated or Divorced 
 
9 
 
4 
 
Education 
  
 
       Completed High School or Less 
 
10 
 
5 
 
       Some College or More 
 
14 
 
4 
 
Measurement 
 Pittsburgh Sleep Quality Index (PSQI; Smyth, C., 2003). The PSQI is a 9-item self-
report measure of insomnia. This global sleep index discriminates between good and poor 
sleepers (Smith & Wegener, 2003). The questionnaire measures seven different sleeping 
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areas including subjective sleep quality, sleep latency, sleep duration, habitual sleep 
efficiency, sleep disturbances, use of sleep medication and daytime dysfunction over the 
previous month. Scores are based on a 0 to 3 Likert-type scale in which ‘3’ signifies poorer 
sleep. Global scores range from 0 to 27 and are the result of an algorithm that weighs index 
scores to compute an outcome. Poor sleep quality is operationalized by a global score of 5 
or greater.  
 Internal consistency has been demonstrated to be high with overall Cronbach’s 
alpha of the seven component scores equaling .83 (Smith & Wegener, 2003).  Test-retest 
reliability has been demonstrated by t-test comparisons that failed to show significant 
differences between time one and 28 days later (Smith & Wegener, 2003). The product-
moment correlation between the two times was .85 p < 0.001. Criterion validity has been 
established (Buysse, Reynolds, Monk, Berman, & Kupfer, 1989) showing that the PSQI 
can distinguish good from poor sleepers as accurately as can the integration of an expert 
administered clinical exam, physical exam and polysomnographic testing. The PSQI has 
been shown to be able to assess change after an intervention. In clinical trials of CBT 
interventions, the PSQI scores significantly decreased in participants who participated in 
the intervention (Currie, Wilson, Pontefract, DeLaplante, 2000).   
 Patient Health Questionnaire - 9 (PHQ-9; Spitzer, Kroenke, & Williams, 1999).  
The PHQ-9 is the depression module of the broader Patient Health Questionnaire (PHQ). 
The PHQ-9 assesses each of the 9 DSM-IV diagnostic symptoms of depression with 
Likert-type ratings on a “0” (not at all) to “3” (nearly every day) scale (Range = 0-27).  
Psychometric qualities of the PHQ-9 have been assessed in multiple, large-scale studies 
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involving primary care (Spitzer, Kroenke, & Williams, 1999), ob/gyn (Spitzer et al., 2000), 
and in a general, non-medical population (Martin et al., 2006).  The PHQ-9 demonstrated 
high internal reliabilities (.89 and .86), forty-eight hour test-retest reliability (.84), and 
good evidence of criterion validity by having a reliable inverse relationship with health-
related quality of life measures (Kroenke, Spitzer, & Williams, 2001).  The PHQ can be 
meaningfully applied as a diagnostic proxy for depression (score > or = 10 has 88% 
sensitivity and 88% specificity), and provides a continuous measure of severity (Total 
Score). The PHQ – 9 has been found to be a practical and responsive tool for 
pharmacologic treatments for depression among men and women (Löwe, Schenkel, & 
Carney-Doebeling, 2006). 
Procedure 
 Passive recruitment occurred by means of a sign display in the reception area of a 
psychiatric outpatient clinic. Volunteers consented after being informed of the details and 
limits of their involvement in this study. After consent was given, the participants 
completed the PSQI and PHQ-9 while waiting for his or her psychiatric appointment. Any 
participant returning a PSQI with a global score greater than 5 and also reporting PHQ-9 
scores of 10 or above was randomly assigned to either the treatment or control group. To 
obtain sufficient power to detect differences between the two groups, twenty-four 
participants were randomly assigned to the treatment group and the remaining ten 
participants were randomly assigned to the control group. Power estimates were conducted 
to determine the size of the sample (Cohen, 1988). Four interrelated variables contributed 
to this calculation. The ratio of any three of these variables (power, effect size, alpha and 
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sample size) can determine the fourth variable. Because these variables can not be known 
before the experiment takes place, an estimate of three of these variables can be set and 
used to estimate the fourth. In this case, sample size was determined by estimating the 
other three. With estimates of medium effects size (.4), alpha set to p < .05 and power 
levels estimated at .80, SAS (FPOWER) was used to estimate the appropriate number of 
participants needed.     
 Treatment group. Participants in the treatment group received the brief insomnia 
intervention immediately after giving informed consent. This included a 60-minute CBT 
session (described below and in Appendix A) and a take-home pamphlet reviewing 
essential points of the session. Two weeks following the first session of the intervention, a 
phone interview occurred and focused on resolving any concerns pertaining to 
recommendations given in the first session and addressing any questions about the 
treatment. Two weeks following the second session, the post measures (PSQI and PHQ-9) 
were mailed to each treatment participant with a self-addressed and stamped envelope. 
Four weeks following this measurement, the follow up measures (PSQI and PHQ-9) were 
again mailed to each treatment participant with a self-addressed and stamped envelope. 
After three days of mailing, each measurement packet sent was followed by a phone call to 
encourage the return of the materials. Any participant who did not return data after two 
weeks of mailing received a phone call to ask for oral report of the data. Non-returned or 
reported packets constituted missing data which was not analyzed .  
 It was anticipated that some participants would become unavailable for various 
reasons during the study at a rate no larger than the number who would drop out of such a 
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treatment for insomnia in a non-study intervention. Reasonable efforts were made to assist 
these participants to remain in the study such as being sensitive to individual circumstances 
and inquiring by way of telephone to determine if any resolvable concern existed.  
 Control group. Participants in the control group were provided pre-measurements 
(PSQI and PHQ-9) as described above at their initial visit. Two weeks later, they received 
a phone call reminding of their participation in the study and that they would receive the 
measures in two weeks. Two weeks following the phone call, post measures (PSQI and 
PHQ-9) were mailed to each control participant with a self-addressed and stamped 
envelope. Four weeks following this measurement, follow up measures (PSQI and PHQ-9) 
were again mailed to each control participant with a self-addressed and stamped envelope. 
Finally, the control-group participants were scheduled for an in-person appointment to 
receive the treatment protocol after their last measurement was received. Any participants 
not completing all measurements were offered the treatment protocol.  
Intervention 
 The intervention was a two-session treatment that included one 60-minute in-
person session and follow up session via telephone.  See Appendix A for details. This 
protocol was modeled after a design that was tested and found to have consistent positive 
effects in producing reductions in wake time after sleep onset and reductions in insomnia 
symptoms among veterans (Edinger, & Sampson, 2003). In addition, each treatment-group 
participant during  the CBT session was given a  brochure detailing important points of the 
session (Appendix B).  
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Analysis 
 Data were inspected for outliers. Measures of normality (skewness and kurtosis) 
were evaluated. Homogeneity of variance, linearity and multicolinearity of the dependent 
variable were evaluated to insure assumptions of the statistical method were not violated.  
 Profile analysis was used to test the null hypothesis that global post and follow-up 
sleep measures were not significantly different from baseline sleep measures while 
controlling for initial levels of depression. Profile Analysis was then used to test the null 
hypothesis that global post and follow-up depression measures were  not significantly 
different from baseline depression levels while controlling for initial levels of sleep 
difficulties.  
 Graphical analysis was conducted to determine direction of differences if the null 
hypothesis is rejected. To demonstrate significance, the null hypothesis must be rejected at 
the p < .05 level.  
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Chapter Four 
Results 
 
Prior to analysis, the dependent variables for sleep difficulties and depression (PHQ-9 
initial, PHQ-9 post, PHQ-9 follow-up, PSQI initial, PSQI post and PSQI follow-up) were 
examined through SPSS (statistical package for the social sciences) for accuracy of data 
entry, missing values and fit between their distributions. Only one missing value was 
discovered that could not be recovered which resulted in the loss of the only dropped data 
in this study. Results of measures of skewness revealed that all instances of the dependent 
variables fell within 2-times the standard error of the mean which indicated a significant 
level of skewness did not exist. Measures of kurtosis showed that neither significant 
flatness nor steepness existed among the outcome variables. Each measure fell within 2-
times the standard error of the mean for kurtosis.  
 The dependent variables were examined for univariate and multivariate outliers. 
The conservative estimate of 2 standard deviations of the mean was used as a criterion to 
identify univariate outliers. No instance among the variables fell outside of this criterion. 
Mahalanobis distances were computed by linear regression. No value within these 
distances exceeded the criterion value indicating that no multivariate outliers existed 
among the dependent variables, c2(6, N = 33) = 16.81, p > .05. 
A profile analysis was performed comparing the profile of the level of sleep 
difficulties of the treatment group with the profile of the level of sleep difficulty of the 
control group over the time of the three measurement points with initial levels of 
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depression held constant for all participants. The group by time interaction for level of 
sleep difficulty was statistically significant which indicates a deviation from parallelism of 
the two independent groups, F(2, 33) = 5.29,  p < .05, partial η2 = .43. Sleep difficulty 
scores among the treatment group changed over time in comparison to and independently 
from the wait group.  
 
 
Table 2   
Descriptive statistics for dependent variables by treatment group and wait group 
Treatment Group  Wait Group   
  M SD SE%*  M SD SE%* 
 
PSQI  
Initial 
 
13.7 5.0 65.1  14.78 3.38 69.9 
PSQI  
Post 
 
11.8 5.0 74.5  14.3 3.50 69.2 
PSQI  
Follow up 
 
9.42 5.67 74.8  15.6 3.20 68.4 
PHQ-9  
Initial 
 
15.75 7.29   19.3 4.03  
PHQ-9  
Post 
 
10.88 7.25   19.3 3.47  
PHQ-9  
Follow up 
 
9.58 6.62   19.1 3.9  
 
* Average Sleep Efficiency derived from reported time asleep divided by time spent in bed 
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Figure 1 below plots the profiles of sleep difficulties for the two groups over the 
time of the three measurement points. Whereas there was no significant difference between 
the treatment and wait control group before the intervention, sleep difficulty scores 
declined for the treatment group at four weeks and eight weeks whereas the wait group 
remained relatively stable over the same times. Thus, there was a decrease in sleep 
problems while controlling for initial levels of depression over time in the treatment group 
that was not observed in the wait group.  
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Figure 1: This chart demonstrates the estimated marginal means of participants reported 
levels of difficulties sleeping at initial, post and follow up measurements. 
 
As demonstrated above, multivariate analysis detected average improvements in 
sleep between treatment and wait groups. Case wise analysis also demonstrated differences 
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in sleep between these groups. Of the treatment group participants, 87% improved in 
measures of sleep. Of the control group, only 30% had improvement in sleep. These 
improvements were demonstrated by a marginally small rise in sleep scores. Seventy 
percent of this group remained the same in their level of sleep difficulty or got worse over 
the course of the study.  
In addition to the comparisons made of sleep, the profile analysis compared the 
profile of the level of depression of the treatment group with the profile of the level of 
depression of the wait group over the time of the three measurement points with initial 
levels of sleep difficulties held constant for all participants. The group by time interaction 
for level of depression was statistically significant which indicates a deviation from 
parallelism, F(2, 33) = 8.34,  p < .01, partial η2 = .37. Depression scores among the 
treatment group changed over time in comparison to and independently from the wait 
group.  
Figure 2 plots the profiles of depression levels for the two groups over the time of 
the three measurement points. Whereas there was no significant difference between the 
treatment and wait group before the intervention, depression scores declined after 
treatment at four weeks and eight weeks while the wait group remained relatively stable 
over the same times. Thus, there was a decrease in depression while controlling for initial 
levels of sleep difficulties over time in the treatment group that was not observed in the 
wait group.  
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Figure 2: This chart demonstrates the estimated marginal means of participants reported 
levels of depression at initial, post and follow up measurements. 
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Chapter Five  
Discussion 
The findings of this research support the two hypotheses proposed. Psychiatric outpatients 
participating in a brief intervention for insomnia have significantly lower PSQI scores, a 
global measure of sleep, at post and follow up compared to a control group not receiving the 
intervention when initial levels of depression are held constant. Also, psychiatric outpatients 
participating in the same brief intervention for insomnia have significantly lower PHQ-9 
scores, a measure of depression, at post and follow up compared to a control group not 
receiving the intervention when initial levels of insomnia are held constant. The amount of 
variance accounted for by these variables was small which is expected in such psychological 
constructs. The condition of insomnia in humans has many contributing factors such as 
genetics, changing brain and body chemistries, seasons, medications, drugs, mental illnesses, 
daily stressors, worry and life events, all of which have a different impact on the unique 
individuals they effect. However, because the factors listed above may be closely correlated 
with symptoms of insomnia, decreases in sleep difficulties have the potential to have a 
synergetic effect on many areas of individuals’ lives. A small improvement in restful sleep 
may help improve other areas of difficulty and make improvement in these areas or life more 
likely. An important area where this synergy was observed in this study is in the reduced 
levels of depression found after this treatment for insomnia was administered. Contrary to 
beliefs that insomnia is often secondary to depression, depression may in some cases be 
secondary to insomnia. Some unresponsive instances of depression may be unresponsive 
because the root problem, in some of these cases insomnia, is not being addressed.  
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 These findings have clinical and financial implications. Because medicinal 
interventions for insomnia often have biological side effects and because they often only 
offer nominal increases in restorative sleep, they should be prescribed for insomnia after 
evaluating the possibility of non-chemical strategies. The findings of this study add support 
to the evidence that has been accrued that indicates that behavioral strategies for insomnia 
such as CBT are an effective and implementable tool for reducing symptoms of insomnia. 
At first, prescription of medication seems to be the most efficient treatment for insomnia 
because it takes little time and physician resources. However, non-chemical interventions 
increase the chance that individuals experience the benefit of increased restful sleep that is 
more enduring, has fewer or no biological side effects and is less expensive when 
considering the price of medication, repeat visits to continue medication, treatment for 
addiction to medication and reduction in other psychiatric symptoms that come with actual 
improved restful sleep.  
 As is the case in many research projects, an equilibrium that ranges from complete 
laboratory control to real-life validity must be negotiated. This equation can only be 
balanced by understanding the problem of the research project. In this study, the central 
question required implementation and evaluation of a real-life intervention for insomnia in 
a psychiatric outpatient setting. Previous research has addressed the theoretical and more 
controlled components of this issue in lab settings. Creating a ‘real-life scenario’ was a 
principle that guided decisions in designing this study. For example, when deciding on the 
amount of control to place on the treatment protocol (to use a word-for-word script or to let 
the intervention be guided by CBT principles), it was decided to follow the path that most 
 32 
approximated how service providers in real life would implement such an intervention and 
use a principle-based protocol. This decision-making was used throughout this project to 
make this a useful study for those interested in CBT for insomnia at the actual 
implementation level. Laboratory exactness is not always desirable when this reliability 
does not exist in the real world. 
 However, other lines of research would reveal the elements of this intervention that 
accounts for the actual results. It would be useful to understand the amount of variance that 
was accounted for by individual differences, the stage of change of the participant or 
interpersonal factors present in the therapist/participant relationship. Differentiating among 
the various elements of depression being influenced by this intervention in a factorial 
analysis of individual symptoms would begin to define the nature of depression and its 
synergetic relationship to insomnia. It would also reveal the specific elements of the 
treatment that are necessary which would lead to more efficient, personalized and targeted 
treatment plans for individuals.  
  As mentioned above, the CBT treatment for insomnia reduced levels of insomnia 
and, at the same time, reduced levels of depression. The DSM-IV-TR criterion for Major 
Depression includes nine elements of depression (five of which must be met to qualify for 
the diagnosis). Of these nine elements, four have a direct etiology to, are indistinguishable 
from or are insomnia itself. These elements are anhedonia, psychomotor agitation, fatigue, 
diminished ability to think or concentrate and insomnia itself. The descriptions of insomnia 
and depression are so closely related that it is not surprising that an affective treatment for 
insomnia would also be affective for treating depression. Given the illusive and insidious 
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nature of depression, future studies in this area may open new paradigms for understanding 
depression and may define new treatments that treat the root cause that may be insomnia in 
some cases.  
 One limitation of the study is the lack of multiple providers conducting the 
intervention. One researcher provided the intervention for all participants. In many real-life 
situations, these sets of principles would be taught to a team of service providers who 
would each interpret and deliver the intervention with their own style and individuality. An 
improvement on this study and an area for further study is to examine the implementation 
of the principles of this intervention for insomnia at the training-of- service-providers 
level. A study that compared the reliabilities among different deliverers of this intervention 
to the results of this study would be useful to further understand the actual implementation 
of such a study at the institution level.  
 Several principles were followed in collecting data for this project that were not 
only important for data integrity in evaluating the findings but also translated into 
principles that can be used to make this intervention effective in real-life situations. 
Personal attention to individuals’ unique needs, sound record keeping and follow-up 
tracking in this study resulted in very low instances of missing data and high rates of 
participant follow-through, which will be delineated below.  
 It was assumed in this study that there is not one intervention that will ‘fix’ all 
problems with sleep for everyone. Therefore, diversity among individuals was not only 
assumed but addressed and valued. The protocol for intervention outlines this by providing 
room for building a relationship of trust with each participant and making space for the 
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participant to ask questions. This stance engenders trust in the participant that his or her 
service provider is invested in understanding his or her uniqueness, invites the participant 
to be invested in the process and would account for a certain amount of variance when 
implementing such interventions. For example, in the study a man from a Southeast Asian 
island enrolled in the study after moving to the area without his wife who remained in her 
country. The man was surprised in the planned post-treatment phone call when the 
researcher asked about the pending status of his wife’s travel to the states. He later, at 
follow-up, confessed that he was less invested in the study until he learned that the clinic 
was not only interested in his data but also interested in him as a person. In a post-study 
questionnaire, he said this made him want to fulfill his agreement to implement the 
principles of the intervention for the full time of the study. This personal attention not only 
contributed to more complete data collection, but also is an example of a clinical treatment 
principle that is part of the real-life nature of psychological interventions.  
 Second, sound and efficient record keeping is necessary to keep up with the 
information described above. Process notes that were short and contained pertinent 
information were kept after any interaction with participants. These notes were written 
immediately after each interaction and completed in less than 60 seconds each. They 
contained a sentence describing what transpired and a sentence describing what should be 
followed up on in the next interaction. Also, a free online calendar program was used 
without any identifying information about participants to make precise implementation of 
the components of the intervention possible. The simple calendar program could be 
accessed and edited by any member of the research team. Upon admission to the study, an 
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assigned number was given to the participant and entered into the calendar. The calendar 
was programmed to automatically schedule each step of the intervention for the individual 
and track returned data.  
 Knowing exactly which data had not been returned on time made the principle of 
follow-up tracking possible. When data were not received, the researcher could 
immediately call and resolve any concern that was preventing the return of the data. Often, 
the participant had simply forgotten and was happy to drop the envelop in the mail. Other 
instances involved questions about procedure that were easily explained. This technique 
was instrumental in compiling a complete data set with only one missing response in the 
whole study. Additionally, the tracking systems resulted in greater statistical power to 
detect and lower the probability of Type II error as well as address the real-life problem of 
high drop-out rates among clients of low SES outpatient clinics.  
 In this study, a real limitation that existed was the low effect size. Ideally, a set of 
principles for decreasing sleep problems and co-morbid depression could be implemented 
in outpatient clinics and cure insomnia for anyone participating in the study. In reality, 
only a small amount of variance can be attributed to any psychological intervention. Other 
real factors such as an individual’s ability and willingness to change, timing, external 
resources and internal resources influence the efficacy of the intervention. Marginal means 
of the dependent variables in the results of this study showed average decreases in sleep 
problems and levels of depression for those receiving the insomnia treatment, which is an 
accepted form of statistical analysis for psychological studies. However, this form of 
analysis does not take into account the reality of the human condition. Instead, it lumps all 
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participants together in respective groups and shows that when looking at averages 
between groups, this intervention creates some change in one group compared to another. 
Theoretically, a few really large effect sizes among individuals in one group could create 
the illusion that that group is unique because of the treatment, when in reality, most 
participants in the group did not benefit. However, a case-by-case analysis of this data 
shows that most individuals in the treatment group had some improvement in sleep 
difficulties and depressive symptoms and few participants got worse. This is evidence that 
though effect size is low when all change is averaged within groups, the intervention itself 
is helpful in reducing these symptoms for enduring amounts of time for most people to 
varying degrees depending on other, less controllable factors.  
 These other factors can be better accounted for in future evaluations of similar CBT 
interventions for insomnia by following recommendations (Davidson, Feldman-Stewart, 
Brennenstuhl and Ram, 2007) in a qualitative study that incorporated participant feedback 
of roadblocks to effective treatment of insomnia. Feedback included the findings that many 
patients wanted more recognition of the reality of sleep difficulties by health care 
providers. They felt that insomnia was not regarded as a legitimate medical complaint. 
These same patients felt that not enough information was provided about sleep difficulties 
and options for treatment.  In the present study, this information about options was 
provided by way of take-home brochure. See Appendix B.  
 Recent research has already been conducted that explores these other factors that 
reduce the effect size of insomnia treatments. Specifically, Vincent, Lewycky, and 
Finnegan (2008) found that those who comply with sleep restriction and stimulus control 
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interventions almost always make improvements in symptoms of insomnia. The next 
logical question, which was addressed in the same study, showed that those who do not 
comply with sleep restriction and stimulus control are those who perceive barriers to 
compliance such as boredom and annoyance with the treatment. Addressing these concerns 
of individuals in treatment for insomnia may increase the average effects size of such 
treatments. Others, such as Constantinio, Manber, Ong, Kuo, Huang, and Arnow (2007) 
have recently shown that other common factors including patient expectation and 
therapeutic alliance are effective at distinguishing those who receive benefits from therapy 
and those who do not. Patients who perceived their therapist as critically confrontive or 
low in affiliation were less likely to gain benefits in restful sleep after CBT interventions. 
Attention to these factors will raise the probability of increased average effects sizes in 
such treatment protocols.   
 Adequate information is currently available to make sound recommendations for 
the treatment of insomnia in many populations. The next step is implementation. Research 
that demonstrates real-life, cost-effective, successful implementation models of insomnia 
treatments in many settings will be most important in decreasing costs and side effects 
associated with automatic reliance on pharmaceuticals as a primary treatment for insomnia. 
Being able to efficiently teach the treatment principles of insomnia to health care providers 
at many levels and through many modes such as video, web-based training and literature 
will decrease the negative outcomes of poor sleep and may help decrease stress that 
contributes to symptoms associated mental illnesses such as depression and anxiety. 
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Appendix A 
Brief Insomnia Protocol for Treatment 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1. Introduce self and study. Build report 
and gain useful information by 
expressing genuine interest in 
some details of participant’s life.  
 
2. Explain overview of treatment 
• Time (meet for one hour and 
follow up with three phone calls) 
• Process by which we can train our 
bodies to sleep better without 
using drugs 
• Will be asked to do several things 
for several weeks which will 
result in better sleep 
3. Bedtime Habits 
• Explain how certain things can 
hinder sleep 
• Using caffeine, nicotine or 
alcohol near bedtime (reduce as 
much as possible) 
• Exercising fewer than four hours 
before bedtime 
• Discuss each with participant 
 
4. Stimulus control  
• Avoid all activities in bed to sleep 
and sex (no TV, working, 
computers, reading, resting, 
listening to music, etc) 
 
5. Sleep restriction activities 
• No napping during the day 
(discuss implications; give time 
for questions and concerns) 
• Set regular time for going to bed 
and waking up 
 
6. Wrap up 
• Present summary inquire about 
additional questions and concerns, 
give contact information, express 
confidence in participant and 
program
                Tasks: 
• Overview of brief CBT for insomnia 
• Bedtime habits 
• Stimulus control 
• Sleep restriction strategies 
• Take-home sleep log and summary of 
session 
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Appendix B 
Sleep Brochure for Treatment Intervention page # 1 
 
 
 
 
*Appendix B continued on next page 
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Appendix B (continued) 
 
Sleep Brochure for Treatment Intervention page # 2 
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Appendix C 
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